Antibiotic Resistance, Part 2: Gram-negative Pathogens

被引:15
作者
Oliphant, Catherine M. [1 ]
Eroschenko, Kathryn [1 ]
机构
[1] Idaho State Univ, Coll Pharm, Meridian, ID 83642 USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 01期
关键词
antibiotic; antimicrobial; gram negative; resistance; treatment; MULTIDRUG-RESISTANT; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; INFECTIONS; ENTEROBACTERIACEAE; EPIDEMIOLOGY;
D O I
10.1016/j.nurpra.2014.10.008
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Antimicrobial resistance is rapidly increasing among gram-negative bacteria. Gram-negative bacteria are common causes of community- and nosocomial-acquired infections. Common mechanisms of resistance in gram-negative pathogens include altered target sites, beta-lactamase production, decreased antibiotic penetration, and efflux pumps. The mechanisms of resistance and treatment options for Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa will be discussed in this article. Antimicrobial resistance presents challenges to clinicians in choosing appropriate and effective regimens. Prudent use of antimicrobial agents may reduce the emergence of further resistance in these important gram-negative bacteria.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 30 条
[1]  
[Anonymous], MANDELL DOUGLAS BENN
[2]  
[Anonymous], 2013, Current, V114
[3]  
CDC, 2012, HAEM INFL DIS
[4]  
CDC. Carbapenem-resistant Enterobacteriaceae (CRE) infection: clinician FAQs, 2013, CARB RES ENT CRE INF
[5]  
Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873
[6]  
Centre for Disease Dynamics, RES MAP
[7]  
del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590
[8]  
Donnenberg M.S., 2009, PRINCIPLES PRACTICE, P2815
[9]   Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review [J].
Falagas, Matthew E. ;
Kastoris, Antonia C. ;
Kapaskelis, Anastasios M. ;
Karageorgopoulos, Drosos E. .
LANCET INFECTIOUS DISEASES, 2010, 10 (01) :43-50
[10]   New antibiotic agents in the pipeline and how they can help overcome microbial resistance [J].
Gould, Ian M. ;
Bal, Abhijit M. .
VIRULENCE, 2013, 4 (02) :185-191